SWOG Randomized Phase III Trial of Multimodality Therapy versus Standard of Care Systemic Therapy in HER2 Positive (HER2+) de novo (AJCC Stage IV) Oligometastatic Breast Cancer with Response to Initial Chemotherapy Adult CIRB - Late Phase Emphasis Active Available to Open